Clinical Trial Update: Efficacy of Bifeprunox in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy of bifeprunox in schizophrenia has been terminated; the snippet does not include efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Bifeprunox (bifeprunox)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED